I would think the PDD peer reviewed paper will be later than filing the data with the FDA. Both require all the DNA/RNA data and KEM analysis completed and the peer review process is far from instant.
Hopefully both the FDA filing and peer reviewed paper will be this year, but guidance conclusions from the FDA may not.
I would very much like to see peer reviewed papiers published on PDD and Rett
Sure that will help, but.. Unless there is a PR with headlines which mention FDA, or NDA, or TGA, this stock will not begin to approach the value that I and every other long term bull are expecting.